ArticleHeliyon2023

Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice.

Ruei-Min Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.